faslodex
astrazeneca ab - fulvestrant - sânii neoplasme - terapia endocrină, anti-estrogeni - faslodex is indicated , as monotherapy for the treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:, , not previously treated with endocrine therapy, or, with disease relapse on or after adjuvant antiestrogen therapy, or disease progression on antiestrogen therapy. , , , in combination with palbociclib for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer in women who have received prior endocrine therapy. În pre - sau femeile în pre-menopauză, tratament combinat cu palbociclib ar trebui să fie combinate cu un hormon luteinizant hormonului de eliberare (lhrh) agonist.
fulvestrant sandoz 250 mg
lek pharmaceuticals d.d. - slovenia - fulvestrantum - sol. inj. in seringa preumpluta - 250mg - antagonisti hormonali si substante inrudite antiestrogeni
fulvestrant teva 250 mg
pliva hrvatska d.o.o. (pliva croatia ltd.) - croatia - fulvestrantum - sol. inj. in seringa preumpluta - 250mg - antagonisti hormonali si substante inrudite antiestrogeni
fulvestrant mylan
mylan pharmaceuticals limited - fulvestrant - sânii neoplasme - terapia endocrină - fulvestrant este indicat pentru tratamentul de estrogen receptor pozitiv, avansat local sau metastatic, cancer de sân la femeile în postmenopauză:nu tratați anterior cu terapie endocrine, orwith recidiva bolii sau după adjuvant terapie anti-estrogen, sau progresia bolii pe antiestrogen terapie.
falvax 250 mg
betapharm arzneimittel gmbh - germania - fulvestrantum - sol. inj. in seringa preumpluta - 250mg - antagonisti hormonali si substante inrudite antiestrogeni
fulvestrant rompharm 250 mg
rompharm company s.r.l. - romania - fulvestrantum - sol. inj. in seringa preumpluta - 250mg - antagonisti hormonali si substante inrudite antiestrogeni
fulvestrant sun 250 mg
sun pharmaceutical industries europe b.v. - olanda - fulvestrantum - sol. inj. in seringa preumpluta - 250mg - antagonisti hormonali si substante inrudite antiestrogeni
fulvestrant ever pharma 250 mg
ever pharma jena gmbh - germania - fulvestrantum - sol. inj. in seringa preumpluta - 250mg - antagonisti hormonali si substante inrudite antiestrogeni
fulvestrant accord 250 mg
accord healthcare polska sp. z.o.o. - polonia - fulvestrantum - sol. inj. in seringa preumpluta - 250mg - antagonisti hormonali si substante inrudite antiestrogeni
fulvestrant rompharm 250 mg/5 ml soluţie injectabilă în seringă preumplută
rompharm company srl - fulvestrantum - soluţie injectabilă în seringă preumplută - 250 mg/5 ml